Clinical Trials
8 trialsNCT07544654 2026-05-27
DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy
Boehringer Ingelheim
Phase 3 Not yet recruiting
NCT07595913 2026-05-19
A Study of ZG006 for Injection Versus Investigator-Selected Chemotherapy in Participants With Advanced Neuroendocrine Carcinoma
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 3 Not yet recruiting
NCT07488923 2026-04-29
A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)
Moonlight Bio, Inc
Phase 1 Not yet recruiting
NCT07252661 2025-11-28
Study of ACC-1898 in Adult Participants With Advanced Solid Tumors
AccSalus Biosciences, Inc.
Phase 1 Not yet recruiting
NCT07024277 2025-06-17
Study of ZG006 in Participants With Neuroendocrine Prostate Cancer
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 2 Not yet recruiting
NCT06936735 2025-04-20
Phase I Study of HS-20108 in Participants With Advanced Solid Tumors
Hansoh BioMedical R&D Company
Phase 1 Not yet recruiting
NCT05967481 2023-08-01
Evaluation of Study Experiences of Neuroendocrine Tumor Patients
Power Life Sciences Inc.
Not yet recruiting
NCT05819593 2023-04-19
Evaluating Trends in Anaplastic Thyroid Cancer Patients' Clinical Study Experiences
Power Life Sciences Inc.
Not yet recruiting